article thumbnail

From Public to Private: Do Laid-Off FDA and CDC Employees Have the Skills Pharma and Biotech Need?

World of DTC Marketing

Deep Regulatory Expertise FDA and CDC employees are steeped in the complexities of public health regulation, drug and device approval pathways, and safety monitoring. Their grounding in data-driven decision-making, peer-reviewed research, and public health ethics adds credibility to any medical affairs, safety, or regulatory team.

Pharma 244
article thumbnail

What Makes a Great VP of Medical Affairs

World of DTC Marketing

supporting an NDA/MAA filing, a global launch, or managing a product during a safety signal investigation. Ethics and Compliance as Core, Not Cover Medical Affairs is uniquely positioned to build credibility—or lose it. What to look for: Examples of delivering major milestones under pressure—e.g., The best VPs don’t cut corners.

Medical 171
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma Research Trends: Leveraging Innovation for Smarter Marketing Strategies

Pharma Marketing Network

Research gathered from real-world settings offers invaluable insights into drug efficacy, safety, and patient preferences. Ethical Considerations in Pharma Marketing With great data comes great responsibility. Ethical marketing is essential in maintaining trust.

article thumbnail

Mastering Pharmaceutical Marketing: Strategies to Drive Success in the Pharma Industry

Pharma Marketing Network

Follow FDA guidelines on advertising to ensure your messaging is accurate and ethical. Highlight topics like disease awareness, drug safety, and lifestyle tips to add value to your audience. Platforms like LinkedIn and Twitter are ideal for reaching HCPs, while Instagram works well for patient-focused campaigns.

article thumbnail

What Is Pharmaceutical Marketing and How Is It Evolving in 2025

Pharma Marketing Network

At its core, pharmaceutical marketing still aims to educate stakeholders about the safety, efficacy, and approved uses of medications. Third, ethical data use is becoming a differentiator. Personalization, omnichannel engagement, ethical data use, and patient-centric messaging are leading the way.

article thumbnail

Bolstering Health Technology Assessment With the Help of AI

Pharmaceutical Commerce

Additionally, long-term safety and efficacy data are often unavailable at the time of assessment. Deep learning enhances predictive analytics by detecting early safety signals and unexpected adverse effects from RWD, thereby improving drug safety assessments.

article thumbnail

Easing the mental health burden with psychedelic therapies – what’s next for the regulatory and clinical landscape?

European Pharmaceutical Review

This will lead to more structured, evidence-based treatments for these conditions, addressing the critical questions of safety and long-term efficacy. For now, the regulatory landscape remains focused on ensuring the safety and efficacy of the drug itself. Trials must be designed meticulously, with strong safety protocols in place.